1792. Deputy Neasa Hourigan asked the Minister for Health the steps taken to ensure batches of botulinum toxin products destined for either non-medical use (i.e. aesthetic purposes) or medical use are identified as such by applicants for animal testing project authorisations and the Health Products Regulatory Authority, in order to ensure accurate harm-benefit analyses and evaluations of proposed projects to test such products on animals under Directive 2010/63/EU and SI No.543 of 2012 (as amended); and if he will make a statement on the matter. [38617/23]

Summary

1792. Deputy Neasa Hourigan asked the Minister for Health the steps taken to ensure batches of botulinum toxin products destined for either non-medical use (i.e. aesthetic purposes) or medical use are identified as such by applicants for animal testing project authorisations and the Health Products Regulatory Authority, in order to ensure accurate harm-benefit analyses and evaluations of proposed projects to test such products on animals under Directive 2010/63/EU and SI No.543 of 2012 (as amended); and if he will make a statement on the matter. [38617/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 11 September 2023

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.